Groundbreaking research shows psilocybin therapy equals traditional antidepressants in treating depression with potential ...
Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...
“This bill would require the Alabama Medicaid Agency to cover screening and would also regulate how Medicaid covers prescription drugs used to treat postpartum depression,” the legislation states.
Researchers have debunked key beliefs about addiction, like that a person must hit "rock bottom" before having treatment or ...
Zoloft (sertraline) has interactions with many types of medications, including other antidepressants, amphetamines, blood ...
After SPN-820's failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s ...
Scientists think ketamine relieves depression and anxiety by altering GluN1-2B-2D’s movements, but the effects can vary ...
Investigational drug SPN-820, which activates the mTORC1 pathway, failed to significantly reduce depressive symptoms compared ...
Antidepressants like SSRIs can be life-saving for people struggling with depression, OCD, anxiety and other mental health ...
Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...
Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...
In the second episode of The Deep End, listeners hear what it’s like to live with severe depression and the backstory of an experimental treatment.